Detalhe da pesquisa
1.
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
N Engl J Med
; 387(23): 2113-2125, 2022 12 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36477031
2.
A prediction model for response to immune checkpoint inhibition in advanced melanoma.
Int J Cancer
; 154(10): 1760-1771, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38296842
3.
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
Cancer
; 130(9): 1673-1683, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38198485
4.
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trials.
Int J Cancer
; 153(2): 389-398, 2023 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36843260
5.
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
Int J Cancer
; 152(12): 2493-2502, 2023 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36843274
6.
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 573-586, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36203067
7.
Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice.
Int J Cancer
; 150(2): 317-326, 2022 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34520567
8.
The unfavorable effects of COVID-19 on Dutch advanced melanoma care.
Int J Cancer
; 150(5): 816-824, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34605003
9.
Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study.
BMC Cancer
; 22(1): 653, 2022 Jun 13.
Artigo
Inglês
| MEDLINE | ID: mdl-35698081
10.
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.
Ann Intern Med
; 174(5): 641-648, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33587686
11.
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Br J Cancer
; 124(7): 1222-1230, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33495600
12.
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era.
Br J Cancer
; 124(2): 399-406, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33046804
13.
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.
Cancer Immunol Immunother
; 70(11): 3123-3135, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33774697
14.
Real-world outcomes of advanced melanoma patients not represented in phase III trials.
Int J Cancer
; 147(12): 3461-3470, 2020 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32559817
15.
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
Breast Cancer Res Treat
; 180(3): 675-685, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32124136
16.
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study.
Int J Cancer
; 145(5): 1325-1333, 2019 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30748011
17.
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
Int J Cancer
; 145(1): 274-283, 2019 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30588619
18.
Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study.
Br J Cancer
; 128(5): 707-710, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36564561
19.
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 587-588, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36319872
20.
Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands.
Anticancer Drugs
; 29(6): 579-588, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29634490